Understanding the symptoms, causes, and risk factors of esophageal cancer is important for early detection and prevention.
A multi-site study, backed by an $8 million NIH grant, will evaluate the effectiveness of Lucid Diagnostics' EsoCheck and ...
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.